Platelet-rich plasma is an "Autologous" product produced and then used immediately at the point of care. For these reasons, it is a very safe
treatment. Platelet-rich plasma will have variable efficacy based on formulation and indication, but its safety profile is very high. I have noted transient
pain, stiffness, and swelling but no significant complications in over 9 years of using PRP as a treatment for tendinopathy.
The best present indications for PRP are in patients with chronic tendinopathies such as tennis elbow, patellar tendonitis, and Achilles tendonitis that have
failed traditional treatments and are potentially considering surgery.
Platelet-rich plasma enhances the healing process via a variety of mechanisms. Within platelets and white blood cells are growth factors that help
initiate positive tissue healing responses such as promotion of collagen production and enhancement of vascularity. Importantly, not all PRP is the
same. Some formulations contain both concentrated platelets and concentrated white blood cells. Others contain only concentrated platelets. And the
concentration of these components varies widely by the device that is used to create the PRP. Further, some studies activate PRP with thrombin and
or calcium. This creates a gel that cannot be injected. Other studies rely on in-vivo activation via the endogenous collagen within the tendon. These
various formulations have different levels of bioactivity. As we move forward with PRP research, it will become clear to researchers, clinicians, and
patients that formulation matters. We will likely see different formulations of PRP for different indications.
Platelet-rich plasma is clearly a better treatment for tendon injuries than cortisone. A recent double-blind randomized trial found significantly better outcomes
in the treatment of tennis elbow in patients who received PRP when compared to cortisone. There is also a risk of dermal atrophy or even tendon rupture
when using cortisone.
Tennis elbow has the best data supporting the use of PRP presently. The use of PRP in mild to moderate Achilles tendinopathy patients that have not been
treated with other means is not supported in the literature. We need to continue to develop better data to fully answer that question.
| بالاضافة الى كافة التداخلات الشفائية و التأهيلية باحدث المعايير العالمية ، فأن عيادتنا تقدم الاجراء الاهم عالميا لتسريع الشفاء و اتمامه كليا و ذالك باستخدام عوامل النموا المستخلصة من عينة ماخودة من الحالة نفسها خلال ساعة و احدة |
| هذا الأسلوب الأحدث في العالم يختصر الشفاء من اشهر طويلة الى اسبوعين و يجعله كاملا لتجنب المضاعفات من اصابات المفاصل و الأربطة و العضلات و تقرح الجلد |
| ان البي آر بي للأصابات الرياضية و الحادثية و كذالك للتقرحات الجلدية من المرض و الأصابة طبيعي مئة بالمئة منكم و اليكم نستخلص عوامل الشفاء الكامنة لديكم في البلازما |
| 2010-01-16الصفيحات المكثفة في عيادة د دنيان |
| www.Denian.Net |
| PRP In Sport Injuries Management: |
 |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |
